Arbutus Biopharma Corp
(ABUS - NASDAQ)
5,15 USD
📋 Profilo Aziendale

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

|